Bankrupt genetic-testing firm 23andMe agreed to sell its data bank, which once contained DNA samples from about 15 million ...

Regeneron Pharmaceuticals said on Monday it will buy genomics firm 23andMe Holding for $256 million through a bankruptcy ...

Millions of Americans have embraced at-home DNA kits, hoping to unlock the secrets of their family trees and uncover potential health risks. But behind the promise of ancestry and well-being lies ...

Your DNA results are in — and they're 100 percent the property of a pharmaceutical manufacturer. Put simply, the genetic information of millions is now in the hands of a drugmaker seeking to ...

Amanda M. Castro is a Newsweek Live Blog Editor based in New York. Her focus is reporting on U.S. politics, breaking news, consumer topics, and entertainment. She specializes in delivering in ...

A new study conducted by researchers from the University of Massachusetts-Amherst found that the majority of at-home testing kits leave homeowners with inconclusive results. Because there are no ...

A Rivian exec told BI the nearly 100-year-old German automaker had embraced Rivian's "startup DNA." Rivian and Volkswagen's partnership has injected the nearly 100-year-old German automaker with a ...

Manchester United’s kit details for the UEFA Europa League final in Bilbao have been confirmed, ahead of the huge clash with Tottenham Hotspur. Wednesday’s showpiece occasion, which kicks off ...

Life Kit is here to help you get it together. Want another life hack? Try Life Kit+. You'll support the show and unlock exclusive curated playlists and sponsor-free listening. Learn more at plus ...

After filing for bankruptcy, 23andMe has found a buyer. New York-based Regeneron will pay $256 million for the California company, which was once valued at $6 billion. Importantly, Regeneron ...

NY state Sen. Brad Hoylman-Sigal (left), holding a 3D-printed ghost gun, stands with Manhattan DA Alvin Bragg (center) and Assemblymember Linda Rosenthal, who is holding a machine gun conversion ...